Immunohistochemical assessment of HER2 protein in breast carcinomas - current status
{{output}}
The existing HER2 immunohistochemistry testing is currently experiencing changes in its scoring caused by the recent clinical trials results, especially DESTINY Breast 04 and 06. These trials demonstrated that any detectable immunohistochemical positivity of H... ...
